全部分类
  • Eperezolid
Eperezolid的可视化放大

Eperezolid

Eperezolid(PNU-100592) 是一种恶唑烷酮类抗菌剂,无论甲氧西林对葡萄球菌的敏感性如何(MIC90= 1-4 mg/ml),Eperezolid 都表现出良好的体外抑制活性。

此产品仅用于科学研究,我们不为任何个人用途提供产品和服务

Eperezolid的二维码
  • 库存: 现货
可选规格
  • 包装
    价格
    促销价
    数量
  • 5mg
    ¥3550.00
    2840.00
    - +
  • 10mg
    ¥5012.00
    4010.00
    - +
  • 50mg
    ¥14900.00
    11920.00
    - +
  • 100mg
    ¥20862.00
    16690.00
    - +
已选 0 0
金额: ¥0.00
首页 收藏
  • 货号: ajci17804
  • CAS: 165800-04-4
  • 别名: N-[[(5S)-3-[3-氟-4-[4-(2-羟基乙酰基)-1-哌嗪基]苯基]-2-氧代-5-噁唑烷基]甲基]-乙酰胺,PNU-100592
  • 分子式: C18H23FN4O5
  • 分子量: 394.4
  • 纯度: >98%
  • 溶解度: ≥ 14.05mg/mL in DMSO
  • 储存: Store at -20°C
  • 库存: 现货

Background

MIC50: 0.5, 1.0, 2.0, 1.0, 16.0 and 2.0 mg/L for Pcptostreptococcus, Propionibacterium acnes, Ciostridium pefringens, Clostridium dijiicile, Bactrroidesjagilis, and Fusobacterium, respectivley


Anaerobic bacteria are a common cause of serious infections. Anaerobic species which predominate in clinical infections include the Bacteroides fragilis group, Clostridium spp. and Peptostreptococcus spp. The oxazolidinones are a novel class of synthetic antimicrobials inhibiting the initiation of protein synthesis. Two compounds of this class, eperezolid and linezolid have been shown to inhibit Enterococcus faecalis and Enterococcus faecium.


In vitro: Ninety per cent of all tested Propionibacterium acnes (30 strains), PeptostreptococccuJ spp. (50 strains), C. perjringens (50 strains) and C. dficile (50 strains) were inhibited by <2 mg/L eperezolid. Linezolid showed higher activity (MIC90 4.0 mg/L) against B. jragilis (100 strains) compared to eperezolid (MIC90 16 mg/L) [1].


In vivo: The in vivo effectiveness of eperezolid and linezolid against one strain each of Enterococcus faecalis and vancomycin-resistant Enterococcus faecium was examined in a rat intraabdominal abscess model. Eperezolid was ineffective at doses of 25 mg/kg of body weight twice daily for the reductions in abscess bacterial density for E. faecalis. Against E. faecium infections, intravenous eperezolid was effective, reducing densities approximately 2 log10 CFU/g [2].


Clinical trials: Oral administration of eperezolid (1 000 mg PO) to healthy volunteers has earlier been reported to yield peak serum concentration of 6.28 mg/L, respectively, while the trough concentration was estimated to be 1.62 mg/L, respectively [3].

参考文献:
[1] Edlund C, Oh H, Nord CE.? In vitro activity of linezolid and eperezolid against anaerobic bacteria. Clin Microbiol Infect. 1999;5(1):51-53.
[2] Schülin T, Thauvin-Eliopoulos C, Moellering RC Jr, Eliopoulos GM.? Activities of the oxazolidinones linezolid and eperezolid in experimental intra-abdominal abscess due to Enterococcus faecalis or vancomycin-resistant Enterococcus faecium. Antimicrob Agents Chemother. 1999;43(12):2873-6.
[3] Schaadt RD, Batts DH, Daley-Yates PT, Pawsey SD, Stalker DJ, Zurenko GE.?? Serum inhibitory titers and serum bactericidal titers for human subjects receiving multiple doses of the antibacterial oxazolidinones eperezolid and linezolid. Diagn Microbiol Infect Dis. 1997;28(4):201-4.

没有评价数据

温馨提示 ×
商品已成功加入购物车!
购物车共 0 件商品
去购物车结算